From ADVOCATE to ADVOGATE: is this the end of avacopan?

Authors

Dan Pugh (ORCID: https://orcid.org/0000-0002-2297-2164)
Gavin Chapman (ORCID: https://orcid.org/0000-0002-3513-723X)
Neeraj Dhaun (ORCID: https://orcid.org/0000-0001-9128-6603)

Institutions

Edinburgh Royal Infirmary (GB)
The Queen's Medical Research Institute (GB)

Publication Details

Journal: Arthritis & Rheumatology
Published: 2026-09-24
DOI: https://doi.org/10.1002/art.70352
Primary Topic: Venous Thromboembolism Diagnosis and Management
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

From ADVOCATE to ADVOGATE: is this the end of avacopan?

Dan Pugh, Gavin Chapman, Neeraj Dhaun

Sep 24, 2026

Arthritis & Rheumatology

Venous Thromboembolism Diagnosis and Management

article

From ADVOCATE to ADVOGATE: is this the end of avacopan?

Dan Pugh, Gavin Chapman, Neeraj Dhaun

September 24, 2026article en

Abstract

No abstract available for this paper.

Arthritis & Rheumatology

Edinburgh Royal Infirmary (GB), The Queen's Medical Research Institute (GB)

Reduced inequalities

Openalex Percentile: Top 9%

Venous Thromboembolism Diagnosis and Management

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

From ADVOCATE to ADVOGATE: is this the end of avacopan? — Dan Pugh, Gavin Chapman, et al. · Arthritis & Rheumatology (2026) | TGRS Research Map | TGRS